Evaluation of the Safety Profile of Zolafren®, a Generic Olanzapine Formulation, in Patients with Bipolar Disorder: A Post-Authorization Safety Study
Crossref DOI link: https://doi.org/10.1007/s12325-015-0210-8
Published Online: 2015-05-15
Published Print: 2015-05
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Chudek, Jerzy
Olszanecka-Glinianowicz, Magdalena
Almgren-Rachtan, Agnieszka
Gabryelewicz, Tomasz
Funding for this research was provided by:
Adamed Sp. z o.o.
Text and Data Mining valid from 2015-05-01